Prof. Dr. Raja Atreya



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

IL-3 receptor signalling suppresses chronic intestinal inflammation by controlling mechanobiology and tissue egress of regulatory T cells. (2023) Ullrich K, Derdau J, Baltes C, Battistella A, Rosso G, Uderhardt S, Schulze L, et al. Journal article Further efficacy and safety data for maintenance upadacitinib in ulcerative colitis (2023) Atreya R, Neurath M Journal article Protective effect of the novel calcineurin inhibitor voclosporin in experimental colitis (2023) Lindemann A, Roth D, Koop K, Neufert C, Zundler S, Atreya R, Neurath M, Leppkes M Journal article Case Report: IBD-like colitis following CAR T cell therapy for diffuse large B cell lymphoma (2023) Zundler S, Vitali F, Kharboutli S, Völkl S, Polifka I, Mackensen A, Atreya R, et al. Journal article Interleukin 36 receptor-inducible matrix metalloproteinase 13 mediates intestinal fibrosis (2023) Koop K, Enderle K, Hillmann M, Ruspeckhofer L, Vieth M, Sturm G, Trajanoski Z, et al. Journal article Increased Motility and Suppression of Ex Vivo–Expanded Regulatory T Cells Designed for Adoptive Transfer Therapy in Ulcerative Colitis (2023) Müller T, Liu L, Czerwinski T, Wiesinger M, Dedden M, Paap EM, Ullrich K, et al. Journal article The sphingosine-1-phosphate receptor agonist etrasimod in ulcerative colitis (2023) Atreya R, Neurath M Journal article LPA receptor 1 (LPAR1) is a novel interaction partner of Filamin A that promotes Filamin A phosphorylation, MRTF-A transcriptional activity and oncogene-induced senescence (2022) Konopa A, Meier M, Franz M, Bernardinelli E, Vögele AL, Atreya R, Ribback S, et al. Journal article Induction of microRNA-124 as a novel therapeutic concept in ulcerative colitis (2022) Atreya R, Neurath M Journal article Efficacy of Upadacitinib Dose Escalation in a Phase 3 Long-Term Extension Ulcerative Colitis Study (2022) Panaccione R, Long M, Ran Z, Atreya R, Nakase H, Zhou W, Yao X, et al. Conference contribution